IL99123A0 - Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives - Google Patents

Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives

Info

Publication number
IL99123A0
IL99123A0 IL99123A IL9912391A IL99123A0 IL 99123 A0 IL99123 A0 IL 99123A0 IL 99123 A IL99123 A IL 99123A IL 9912391 A IL9912391 A IL 9912391A IL 99123 A0 IL99123 A0 IL 99123A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
wasting diseases
estrogen derivatives
bone wasting
Prior art date
Application number
IL99123A
Other languages
English (en)
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of IL99123A0 publication Critical patent/IL99123A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL99123A 1990-08-10 1991-08-08 Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives IL99123A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56576390A 1990-08-10 1990-08-10

Publications (1)

Publication Number Publication Date
IL99123A0 true IL99123A0 (en) 1992-07-15

Family

ID=24259992

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99123A IL99123A0 (en) 1990-08-10 1991-08-08 Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives

Country Status (13)

Country Link
EP (1) EP0474374A1 (fr)
JP (1) JPH04230632A (fr)
KR (1) KR930003924A (fr)
AU (1) AU8166191A (fr)
CA (1) CA2048810A1 (fr)
FI (1) FI913791A (fr)
HU (1) HUT59605A (fr)
IE (1) IE912832A1 (fr)
IL (1) IL99123A0 (fr)
NO (1) NO913117L (fr)
PT (1) PT98626A (fr)
ZA (1) ZA916317B (fr)
ZW (1) ZW11391A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
IL120265A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists
DE19815060A1 (de) * 1998-04-03 1999-10-14 Jenapharm Gmbh Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie
AU2223600A (en) * 1999-01-06 2000-07-24 Cedars-Sinai Medical Center Hormone replacement for breast cancer patients
AU2003234637B2 (en) * 2002-05-24 2009-04-30 The Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
KR101586336B1 (ko) * 2014-08-06 2016-01-18 한국생명공학연구원 에스트로피페이트(Estropipate) 또는 이의 약학적으로 허용 가능한 염을 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
JP7154616B2 (ja) * 2017-06-01 2022-10-18 ネクシオン バイオテック カンパニー リミテッド 骨関連疾患の予防または治療のための薬学組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0559240B1 (fr) * 1987-09-24 2001-12-05 Jencap Research Limited Packages contraceptives contenant de l'estrogen et du progestin
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case

Also Published As

Publication number Publication date
PT98626A (pt) 1992-06-30
FI913791A (fi) 1992-02-11
ZW11391A1 (en) 1993-04-07
HU912646D0 (en) 1992-01-28
CA2048810A1 (fr) 1992-02-11
NO913117D0 (no) 1991-08-09
NO913117L (no) 1992-02-11
ZA916317B (en) 1993-04-28
AU8166191A (en) 1992-02-13
HUT59605A (en) 1992-06-29
EP0474374A1 (fr) 1992-03-11
JPH04230632A (ja) 1992-08-19
FI913791A0 (fi) 1991-08-09
KR930003924A (ko) 1993-03-22
IE912832A1 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
HUP9600211A3 (en) Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them, as an activ ingredient
HUT70034A (en) Process for preparing pharmaceutical compositions containing dipyridamole for the treatment of proliferative diseases
ZA916583B (en) 3-amidopyrazole derivatives,process for preparing these and pharmaceutical compositions containing them
HUT72639A (en) Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation
HUP9601033A3 (en) Benzofurane derivatives, process for their preparation, use of them as intermediate and pharmaceutical compositions containing the compounds
HUP9900386A3 (en) Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
HUP9901326A3 (en) Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
IL99123A0 (en) Pharmaceutical compositions for treatment of bone wasting diseases,comprising estrogen derivatives
HUP9802393A3 (en) Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates
GR3034582T3 (en) Substituted 4-phenyl thiazole derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9903103A3 (en) Use of a pleuromutilin derivative for the preparation of pharmaceutical compositions treating veterinary diseases caused by increasing stocking density
EP0558961A3 (en) Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them
HU900746D0 (en) Process for preparation of 2,3,23-trihydroxy-urz-12-en and it's derivatives and for pharmaceutical compositions containing that compounds
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
HUP9901680A3 (en) Use of piperazin-, piperidin- or hexahidropiridazin derivatives for the preparation of pharmaceutical compositions, new piperazin derivatives and pharmaceutical compositions containing these compounds
HUP0202371A3 (en) Diacylhydrazine derivatives, process for producing them, use of these derivatives for producing of pharmaceutical compositions and pharmaceutical compositions
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
HUP9602324A3 (en) Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them
HUP9801925A3 (en) Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons
IL130831A (en) Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases